respiratori
syncyti
viru
rsv
viral
agent
frequent
involv
lower
respiratori
tract
infect
lrti
infant
year
age
develop
countri
new
oligochromatograph
assay
rsv
design
optim
specif
detect
identif
rsv
subtyp
b
test
evalu
clinic
sampl
hospit
children
use
immunochromatographi
ic
test
viru
isol
cultur
inhous
realtim
polymeras
chain
reaction
rtpcr
virus
caus
lrti
investig
cell
cultur
pcrbase
test
sixtytwo
patient
infect
rsv
addit
adenoviru
influenza
b
parainfluenza
human
metapneumoviru
detect
rate
rang
proport
patient
mix
infect
sensit
specif
posit
neg
predict
valu
respect
rsv
ic
rate
viral
detect
coinfect
similar
previous
report
seri
final
find
rsv
rapid
easytoperform
techniqu
detect
rsv
identif
subtyp
b
lrti
research
group
alphabet
order
j
batll
garrido
bronchiol
lead
caus
hospit
infant
less
year
age
develop
countri
mainli
due
respiratori
syncyti
viru
rsv
although
mortal
rsv
infect
develop
countri
infect
increas
risk
seriou
complic
infant
cardiovascular
diseas
cystic
fibrosi
immunodefici
among
condit
besid
infant
elderli
sever
immunocompromis
individu
also
higher
risk
seriou
rsv
infect
rsv
epidem
mainli
occur
winter
temper
climat
season
peak
frequent
isol
viru
children
acut
lower
respiratori
tract
infect
lrti
associ
high
rate
hospit
emerg
depart
visit
rsv
infect
repres
etiolog
diagnosi
major
sever
respiratori
infect
children
detect
viru
critic
control
nosocomi
transmiss
isol
patient
accord
rsv
statu
design
nurs
staff
accordingli
rsv
detect
also
found
reduc
unnecessari
antibiot
treatment
length
hospit
stay
earli
sensit
detect
rsv
especi
import
rsv
influenza
iv
epidem
coincid
hospit
rate
highest
addit
rsv
iv
rhinoviru
rv
adenoviru
av
parainfluenza
viru
piv
recent
discov
human
metapneumoviru
hmpv
frequent
implic
lrti
episod
diagnost
method
use
viral
detect
includ
cell
cultur
immunofluorescenceantigen
detect
nucleic
acidpolymeras
chain
reaction
pcr
base
test
viru
isol
cell
cultur
remain
use
approach
viral
diseas
diagnosi
delay
obtain
result
repres
drawback
antigen
detect
immunochromatographi
ic
test
option
laboratori
equip
molecular
test
sensit
low
especi
adult
patient
test
base
nucleic
acid
amplif
rapid
sensit
appear
suitabl
approach
high
cost
imped
widespread
adopt
firstchoic
diagnost
techniqu
rsv
detect
studi
tradit
pcr
pcrelisa
enzym
link
immunosorb
assay
liquid
array
realtim
pcr
object
present
studi
evalu
new
commerci
assay
rsv
sporsv
vircel
detect
rsv
human
clinic
sampl
addit
rsv
viral
agent
involv
lrti
studi
use
cell
cultur
av
iva
ivb
molecular
method
rtpcr
hmpv
rtpcr
hmpv
experiment
oligochromatograph
assay
hmpv
spohmpv
similar
design
sporsv
sporsv
pcrbase
method
coupl
dipstick
devic
enabl
rapid
less
laborintens
detect
amplif
product
yield
result
within
short
overal
turnaround
time
h
includ
rna
extract
revers
transcript
pcr
strip
hybrid
period
nasal
wash
nw
oropharyng
swab
op
obtain
patient
lrti
admit
pediatr
depart
hospit
tertiari
hospit
almeria
southern
spain
result
sporsvassay
compar
ic
test
inhous
rtpcr
rsv
rtpcrrsv
viral
cultur
applic
assay
routin
rsv
test
discuss
studi
includ
pediatr
patient
diagnos
lrti
admit
hospit
august
august
collect
specimen
nw
opss
parent
inform
consent
sign
everi
recruit
patient
briefli
one
tube
aspir
trap
connect
vacuum
sourc
suction
cathet
appropri
size
ml
steril
physiolog
salin
instil
one
nostril
aspir
nw
collect
procedur
done
nostril
aspir
trap
op
swab
posterior
pharynx
place
viral
transport
medium
vircel
spain
biomed
spain
nw
op
rapidli
transport
laboratori
kept
maximum
h
aliquot
nw
test
ic
tru
rsv
meridian
bioscienc
remain
nw
portion
op
frozen
sent
vircel
laboratori
viru
isol
molecular
test
project
previous
approv
region
research
committe
immunochromatographi
test
tru
rsv
meridian
bioscienc
briefli
nw
ad
tube
contain
sampl
diluent
mixtur
vortex
test
strip
ad
tube
secur
place
result
read
min
incub
preliminari
step
steril
bed
ad
sampl
vortex
opss
swab
discard
vortex
sampl
decontamin
ad
antibiot
mixtur
biowhittak
lonza
usa
incub
h
volum
sampl
inocul
shellvial
tube
follow
cell
line
two
two
mdck
one
vircel
spain
shellvial
centrifug
g
min
centrifug
shellvial
incub
h
discard
inoculum
ml
mainten
medium
minim
essenti
medium
biowhittak
lonza
usa
without
fetal
bovin
serum
ad
shellvial
ml
special
mainten
medium
minim
essenti
medium
biowhittak
lonza
usa
without
fetal
bovin
serum
tcpktreat
trypsin
worthington
biochem
usa
ad
mdck
shellvial
mdck
shellvial
shellvial
incub
h
stain
direct
immunofluoresc
assay
follow
monoclon
antibodi
one
shellvial
rsv
one
shellvial
adenoviru
one
mdck
shellvial
influenza
one
mdck
shellvial
influenza
b
one
shellvial
parainfluenza
monoclon
antibodi
vircel
spain
stain
shell
vial
examin
fluoresc
microscop
magnif
qiaamp
viral
rna
mini
spin
protocol
qiagen
germani
follow
order
extract
nucleic
acid
clinic
specimen
use
nasopharyng
wash
pharyng
swab
transport
medium
final
nucleic
acid
elut
elut
buffer
includ
kit
store
analysi
rtpcr
sporsv
beacon
design
program
premier
biosoft
palo
alto
ca
use
primer
probe
design
sporsv
develop
primer
probe
design
discrimin
rsv
subtyp
b
singl
pcr
use
polymeras
l
gene
target
differ
refer
sequenc
use
detect
rsv
subtyp
access
number
b
access
number
isol
rna
reversetranscrib
use
affinityscript
multipl
temperatur
revers
transcriptas
system
stratagen
usa
reaction
contain
extract
rna
affinityscript
rt
buffer
mm
dtt
mm
dntp
affinityscript
multipl
temperatur
revers
transcriptas
mm
random
hexam
fermenta
lithuania
final
volum
mix
tube
incub
h
enzym
inactiv
min
cdna
obtain
revers
transcript
process
use
oligochromatograph
assay
realtim
pcr
oligochromatograph
assay
rsv
sporsv
commerci
pcrbase
method
coupl
dipstick
devic
enabl
rsv
subtyp
subtyp
b
identif
respiratori
sampl
pcr
mix
suppli
lyophil
format
contain
addit
oligo
pair
human
gene
fragment
use
intern
amplif
control
coamplifi
simultan
target
sequenc
rsv
fragment
rna
polymeras
l
gene
allow
test
qualiti
absenc
inhibitori
substanc
sampl
detect
thermal
cycler
malfunct
incorrect
pcr
mixtur
poor
dna
polymeras
activ
pcr
carri
final
volum
cdna
plu
pcr
mix
pcr
perform
labcycl
instrument
sensoquest
germani
follow
program
min
cycl
one
cycl
min
pcr
product
detect
mean
dipstick
follow
kit
instruct
perform
hybrid
denatur
pcr
product
dilut
run
solut
place
thermal
block
set
amplif
product
hybrid
dipstick
use
two
specif
probe
bound
colloid
gold
four
probe
immobil
onto
membran
run
test
describ
elsewher
strip
two
specif
band
rsv
subtyp
rsv
subtyp
b
third
specif
line
amplif
control
line
appear
human
globin
gene
sampl
amplifi
control
line
top
strip
react
excess
colloid
gold
monitor
flow
liquid
along
strip
final
read
visual
accomplish
min
incub
reactiv
confirm
visual
red
line
fig
entir
process
last
min
n
gene
rsv
subtyp
b
select
target
realtim
amplif
primer
probe
recommend
mlinaricgalinov
et
al
use
specif
probe
rsv
subtyp
subtyp
b
label
hex
fam
end
respect
probe
label
quencher
end
sampl
assay
reaction
mixtur
cdna
use
brilliant
ii
qpcr
master
mix
stratagen
usa
primer
probe
combin
multipl
pcr
follow
van
elden
et
al
amplif
detect
perform
stratagen
realtim
thermocycl
follow
program
min
activ
taq
polymeras
cycl
posit
neg
control
includ
run
primer
recommend
ebihara
et
al
use
fragment
f
gene
amplifi
pcr
condit
author
recommend
condit
use
realtim
mix
kapa
sybr
fast
kapa
biosystem
amplif
program
follow
min
cycl
melt
curv
min
slope
continu
read
check
specif
amplifi
product
comparison
assay
done
use
mcnemar
nonparametr
test
pair
proport
specimen
consid
trueposit
posit
cultur
molecular
test
rtpcr
sporsv
patient
least
one
specimen
consid
rsvinfect
report
pvalu
twosid
p
consid
signific
cohen
kappa
index
use
determin
concord
rtpcr
sporsv
test
total
specimen
test
nw
op
avail
patient
nw
alon
patient
op
alon
six
patient
mean
age
patient
year
rang
day
year
sixtytwo
patient
least
one
posit
specimen
rsv
rsv
subtyp
three
rsv
subtyp
b
two
unknown
subtyp
specimen
assay
sporsv
rtpcrrsv
spohmpv
rtpcr
hmpv
cell
cultur
nw
assay
ic
sensit
specif
posit
neg
predict
valu
respect
sporsv
respect
rtpcrrsv
viral
cultur
show
sensit
neg
predict
valu
ic
show
sensit
specif
predict
posit
valu
neg
predict
valu
tabl
sporsv
rtpcrrsv
significantli
differ
sensit
p
specif
pcrbase
method
significantli
sensit
ic
p
viral
cultur
p
perform
two
molecular
techniqu
sporsv
rtpcrrsv
similar
high
concord
found
kappa
index
overal
specimen
posit
neg
techniqu
differ
evalu
specimen
report
detail
tabl
hmpv
specimen
five
op
nw
correspond
patient
posit
result
rtpcrhmpv
spohmpv
six
patient
also
posit
virus
three
hmpv
rsv
one
hmpv
rsv
ivb
one
hmpv
ivb
one
hmpv
use
cell
cultur
av
ivb
rsv
isol
patient
respect
four
patient
mix
viral
cultur
rsv
av
two
case
rsv
one
case
av
one
case
overal
patient
viral
etiolog
found
ten
patient
mix
infect
among
rsvinfect
patient
nw
op
avail
nw
posit
case
op
case
although
differ
reach
statist
differ
analysi
done
regard
rsv
infect
statu
patient
sensit
detect
rsv
confid
interv
ci
sporsv
ci
rtpcrrsv
evalu
new
commerci
kit
rsv
rsv
detect
two
type
respiratori
specimen
nw
op
hospit
pediatr
patient
lrti
use
viral
cultur
posit
realtim
pcr
protocol
rsv
sporsv
refer
method
also
evalu
perform
nw
tru
rsv
ic
test
routin
use
set
rsv
detect
although
numer
pcr
method
develop
detect
rsv
clinic
sampl
discrimin
rsv
subtyp
b
distinguish
differ
viral
attach
g
nuclear
n
protein
still
clear
whether
sever
infect
differ
subtyp
author
report
subtyp
infect
sever
other
found
differ
relationship
observ
rsv
epidem
pattern
circul
rsv
subtyp
although
suggest
shift
predomin
strain
even
within
subtyp
may
compromis
popul
previous
acquir
immun
favor
new
strain
rsv
subtyp
percentag
differ
markedli
among
differ
countri
region
season
predomin
either
subtyp
b
concurr
circul
thu
studi
croatia
found
subtyp
b
infect
fourfold
common
two
differ
outbreak
zagreb
counti
wherea
studi
unit
state
found
patient
infect
strain
strain
b
strain
seri
high
predomin
subtyp
infect
subtyp
b
infect
case
coinfect
studi
proven
viral
infect
patient
rsv
detect
patient
uniqu
caus
infect
patient
caus
coinfect
virus
seven
patient
thu
rsv
repres
almost
viral
infect
virus
hmpv
av
ivb
detect
rate
total
rate
mix
infect
although
data
similar
previous
report
seri
one
limit
studi
rv
investig
molecular
method
proven
sensit
combin
convent
viral
cultur
shell
vial
cultur
adult
variou
diseas
infant
whose
viral
shed
higher
comparison
adult
improv
detect
rsv
particular
import
infant
age
year
rsv
common
caus
bronchiol
state
use
rtpcr
adult
respiratori
rsv
infect
reveal
markedli
higher
number
posit
case
comparison
viral
cultur
low
sensit
viral
cultur
present
studi
attribut
low
viral
shed
incorrect
sampl
method
crucial
transport
sampl
ice
process
within
h
order
improv
sensit
cultur
techniqu
author
underlin
need
immedi
cultur
patient
specimen
increas
cell
cultur
sensit
detect
rsv
ic
test
use
studi
tru
rsv
show
rather
low
sensit
specif
ppv
valu
high
despit
test
mani
specimen
outsid
rsv
season
low
preval
may
decreas
specif
type
antigen
detect
test
rapid
antigen
detect
assay
shown
even
lower
sensit
respect
rtpcr
test
falseneg
result
ic
may
attribut
small
amount
viral
particl
sampl
studi
sensit
valu
similar
sporsv
rtpcrrsv
rang
previous
report
pcrbase
method
specif
also
high
sporsv
rtpcrrsv
addit
sporsv
includ
pcr
amplif
intern
control
human
gene
sinc
falseneg
result
result
presenc
sampl
pcr
inhibitor
remov
extract
process
inhibit
observ
sampl
test
sporsv
studi
also
compar
efficaci
nasopharyng
oropharyng
sampl
wide
use
author
report
nasopharyng
wash
superior
nasopharyng
swab
iv
rv
coronaviru
infect
meerhoff
et
al
use
rtpcr
obtain
sensit
nasal
swab
versu
nasopharyng
aspir
howev
similar
sensit
obtain
rsv
detect
use
differ
type
sampl
pediatr
adult
popul
present
studi
posit
result
obtain
nw
opss
vs
differ
signific
maxim
sensit
valu
achiev
nw
op
could
test
sporsv
rtpcrrsv
previous
note
research
warrant
order
confirm
use
type
specimen
increas
test
sensit
conclus
rsv
viral
agent
frequent
involv
lrti
thu
rapid
accur
test
detect
viru
vital
improv
etiolog
diagnosi
lrti
also
support
procedur
reduc
nosocomi
infect
among
hospit
children
furthermor
abil
discrimin
rsv
subtyp
discrimin
improv
understand
rsv
antigen
variabl
facilit
futur
vaccin
develop
present
studi
ic
techniqu
demonstr
low
sensit
high
specif
posit
predict
valu
pcrbase
method
show
high
sensit
specif
hospit
set
costeffect
option
rsv
diagnosi
ic
method
howev
especi
rsv
season
preval
high
neg
specimen
retest
sensit
pcrbase
method
accord
result
rsv
rapid
easi
perform
valid
techniqu
purpos
